These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 11234758

  • 1. Hypothalamic orexin-A-immunpositive neurons express Fos in response to central glucopenia.
    Briski KP, Sylvester PW.
    Neuroreport; 2001 Mar 05; 12(3):531-4. PubMed ID: 11234758
    [Abstract] [Full Text] [Related]

  • 2. Site-specific induction of Fos immunoreactivity in preoptic and hypothalamic NADPH-positive neurons during glucoprivation.
    Briski KP, Sylvester PW.
    Neuroendocrinology; 1999 Mar 05; 69(3):181-90. PubMed ID: 10087450
    [Abstract] [Full Text] [Related]

  • 3. Type II glucocorticoid receptor involvement in habituated activation of lateral hypothalamic area orexin-A-immunopositive neurons during recurring insulin-induced hypoglycemia.
    Kale AY, Paranjape SA, Briski KP.
    Neurosci Res; 2006 Nov 05; 56(3):309-13. PubMed ID: 16997409
    [Abstract] [Full Text] [Related]

  • 4. Glucoprivic induction of Fos immunoreactivity in hypothalamic dopaminergic neurons.
    Briski KP.
    Neuroreport; 1998 Jan 26; 9(2):289-95. PubMed ID: 9507971
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oxytocin and vasopressin neurones in principal and accessory hypothalamic magnocellular structures express Fos-immunoreactivity in response to acute glucose deprivation.
    Briski KP, Brandt JA.
    J Neuroendocrinol; 2000 May 26; 12(5):409-14. PubMed ID: 10792579
    [Abstract] [Full Text] [Related]

  • 10. Habituation of insulin-induced hypoglycemic transcription activation of lateral hypothalamic orexin-A-containing neurons to recurring exposure.
    Paranjape SA, Vavaiya KK, Kale AY, Briski KP.
    Regul Pept; 2006 Jul 15; 135(1-2):1-6. PubMed ID: 16678283
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of mu and kappa opioid receptor antagonists on glucoprivic induction of Fos immunoreactivity in the rat preoptic area and hypothalamus.
    Briski KP, Teodecki L.
    Brain Res Bull; 1999 Jun 15; 49(3):181-7. PubMed ID: 10435781
    [Abstract] [Full Text] [Related]

  • 15. Effects of restricted feeding on the activity of hypothalamic Orexin (OX)-A containing neurons and OX2 receptor mRNA level in the paraventricular nucleus of rats.
    Kurose T, Ueta Y, Yamamoto Y, Serino R, Ozaki Y, Saito J, Nagata S, Yamashita H.
    Regul Pept; 2002 Mar 15; 104(1-3):145-51. PubMed ID: 11830289
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypoglycemia differentially regulates hypothalamic glucoregulatory neurotransmitter gene and protein expression: role of caudal dorsomedial hindbrain catecholaminergic input.
    Gujar AD, Ibrahim BA, Tamrakar P, Briski KP.
    Neuropeptides; 2013 Jun 15; 47(3):139-47. PubMed ID: 23490004
    [Abstract] [Full Text] [Related]

  • 18. Effects of estradiol on glucoprivic transactivation of catecholaminergic neurons in the female rat caudal brainstem.
    Briski KP, Marshall ES, Sylvester PW.
    Neuroendocrinology; 2001 Jun 15; 73(6):369-77. PubMed ID: 11408778
    [Abstract] [Full Text] [Related]

  • 19. Expression of Fos-like proteins in the preoptic area and hypothalamus of the rat brain following intracerebral or peripheral administration of colchicine.
    Gillen E, Briski KP.
    Neurochem Res; 1997 May 15; 22(5):549-54. PubMed ID: 9131632
    [Abstract] [Full Text] [Related]

  • 20. Repeated 2-deoxy-D-glucose-induced glucoprivation attenuates Fos expression and glucoregulatory responses during subsequent glucoprivation.
    Sanders NM, Ritter S.
    Diabetes; 2000 Nov 15; 49(11):1865-74. PubMed ID: 11078453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.